BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141:460-6; discussion 466-7. [PMID: 16702517 DOI: 10.1001/archsurg.141.5.460] [Cited by in Crossref: 297] [Cited by in F6Publishing: 250] [Article Influence: 18.6] [Reference Citation Analysis]
Number Citing Articles
1 Desai NB, Laine AM, Timmerman RD. Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.Br J Radiol. 2017;90:20160500. [PMID: 28008774 DOI: 10.1259/bjr.20160500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nakai T, Ishikawa H, Tokoro T, Okuno K. The Clinical Risk Score Predicts the Effectiveness of Adjuvant Chemotherapy for Colorectal Liver Metastasis. World J Surg 2015;39:1527-36. [DOI: 10.1007/s00268-015-2980-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Drazer MW, Salama JK, Hahn OM, Weichselbaum RR, Chmura SJ. Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting? Expert Review of Anticancer Therapy 2016;16:625-32. [DOI: 10.1080/14737140.2016.1178577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Chang HHL, Leeper WR, Chan G, Quan D, Driman DK. Infarct-like Necrosis: A Distinct Form of Necrosis Seen in Colorectal Carcinoma Liver Metastases Treated With Perioperative Chemotherapy. American Journal of Surgical Pathology 2012;36:570-6. [DOI: 10.1097/pas.0b013e31824057e7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
5 Shin H, Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC. Solitary colorectal liver metastasis after curative intent surgery: prognostic factors affecting outcomes and survival. ANZ J Surg 2019;89:61-7. [PMID: 30484933 DOI: 10.1111/ans.14933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kim M, Son SH, Won YK, Kay CS. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int 2014;2014:340478. [PMID: 24868526 DOI: 10.1155/2014/340478] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol 2007;34:177-85. [PMID: 17560979 DOI: 10.1053/j.seminoncol.2007.03.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
8 Stintzing S, Grothe A, Hendrich S, Hoffmann RT, Heinemann V, Rentsch M, Fuerweger C, Muacevic A, Trumm CG. Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases. Acta Oncol. 2013;52:971-977. [PMID: 23409768 DOI: 10.3109/0284186x.2013.766362] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
9 Agcaoglu O, Aliyev S, Karabulut K, El-Gazzaz G, Aucejo F, Pelley R, Siperstein AE, Berber E. Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg 2013;37:1333-9. [PMID: 23460452 DOI: 10.1007/s00268-013-1981-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
10 Helmberger T. [Interventional procedures for hepatic metastases]. Chirurg. 2010;81:542-550. [PMID: 20502849 DOI: 10.1007/s00104-010-1888-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kirichenko A, Gayou O, Parda D, Kudithipudi V, Tom K, Khan A, Abrams P, Szramowski M, Oliva J, Monga D. Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors. HPB (Oxford). 2016;18:88-97. [PMID: 26776856 DOI: 10.1016/j.hpb.2015.07.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
12 Abdalla EK, Vauthey J. Colorectal Metastases: Resect or Ablate? Ann Surg Oncol 2006;13:602-3. [DOI: 10.1245/aso.2006.09.920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lee KH, Chen WS, Jiang JK, Yang SH, Wang HS, Chang SC, Lan YT, Lin CC, Lin HH, Huang SC, Cheng HH, Chao Y, Teng HW. The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon. Br J Cancer 2021;125:816-25. [PMID: 34188197 DOI: 10.1038/s41416-021-01470-2] [Reference Citation Analysis]
14 Zhang YF, Mao R, Chen X, Zhao JJ, Bi XY, Li ZY, Zhou JG, Zhao H, Huang Z, Sun YK, Cai JQ. Prognostic Analysis of 102 Patients with Synchronous Colorectal Cancer and Liver Metastases Treated with Simultaneous Resection. Chin Med J (Engl) 2017;130:1283-9. [PMID: 28524826 DOI: 10.4103/0366-6999.206349] [Reference Citation Analysis]
15 de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA, Schulick RD, Capussotti L, Dejong CH, Pawlik TM. Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 2011;15:336-44. [PMID: 21108017 DOI: 10.1007/s11605-010-1391-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
16 Yazici P, Akyuz M, Yigitbas H, Dural C, Okoh A, Aydin N, Berber E. A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation. Surg Endosc. 2017;31:1269-1274. [PMID: 27444839 DOI: 10.1007/s00464-016-5105-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
17 Bremers A, Ruers T. Prudent application of radiofrequency ablation in resectable colorectal liver metastasis. European Journal of Surgical Oncology (EJSO) 2007;33:752-6. [DOI: 10.1016/j.ejso.2007.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 White SB, Zhang Z, Chen J, Gogineni VR, Larson AC. Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer. Journal of Vascular and Interventional Radiology 2018;29:1764-9. [DOI: 10.1016/j.jvir.2018.07.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
19 Ribero D, Viganò L, Amisano M, Capussotti L. Prognostic factors after resection of colorectal liver metastases: from morphology to biology. Future Oncol 2013;9:45-57. [PMID: 23252563 DOI: 10.2217/fon.12.159] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
20 Piltch A, Zhang F, Hayashi J. Culture and characterization of thymic epithelium from autoimmune NZB and NZB/W mice. Cell Immunol 1990;131:325-37. [PMID: 2242501 DOI: 10.1016/0008-8749(90)90258-s] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
21 Awad MM, Devgan L, Kamel IR, Torbensen M, Choti MA. Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings. HPB (Oxford). 2007;9:357-362. [PMID: 18345319 DOI: 10.1080/13651820701646222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
22 Schiffman SC, Kim KH, Tsung A, Marsh JW, Geller DA. Laparoscopic versus open liver resection for metastatic colorectal cancer: a metaanalysis of 610 patients. Surgery. 2015;157:211-222. [PMID: 25282529 DOI: 10.1016/j.surg.2014.08.036] [Cited by in Crossref: 93] [Cited by in F6Publishing: 68] [Article Influence: 11.6] [Reference Citation Analysis]
23 Vauthey JN, Nordlinger B, Kopetz S, Poston G. Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out. Ann Surg Oncol. 2010;17:1983-1986. [PMID: 20232164 DOI: 10.1245/s10434-010-1007-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
24 Page AJ, Weiss MJ, Pawlik TM. Surgical management of noncolorectal cancer liver metastases: Noncolorectal Liver Metatases. Cancer 2014;120:3111-21. [DOI: 10.1002/cncr.28743] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
25 Labgaa I, Slankamenac K, Schadde E, Jibara G, Alshebeeb K, Mentha G, Clavien P, Schwartz M. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study. The American Journal of Surgery 2018;215:125-30. [DOI: 10.1016/j.amjsurg.2017.09.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Buell JF, Thomas MT, Rudich S, Marvin M, Nagubandi R, Ravindra KV, Brock G, McMasters KM. Experience with more than 500 minimally invasive hepatic procedures. Ann Surg. 2008;248:475-486. [PMID: 18791368 DOI: 10.1097/sla.0b013e318185e647] [Cited by in Crossref: 76] [Cited by in F6Publishing: 102] [Article Influence: 5.4] [Reference Citation Analysis]
27 Chansangrat J, Keeratibharat N. Portal vein embolization: rationale, techniques, outcomes and novel strategies. Hepat Oncol 2021;8:HEP42. [PMID: 34765107 DOI: 10.2217/hep-2021-0006] [Reference Citation Analysis]
28 Abdalla EK. The Truth About Radiofrequency Ablation and Laparoscopic Liver Resection. Annals of Surgery 2011;253:841-2. [DOI: 10.1097/10.1097/sla.0b013e3182120b18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
29 Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford). 2011;13:774-782. [PMID: 21999590 DOI: 10.1111/j.1477-2574.2011.00370.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
30 Liersch T, Meller J, Bittrich M, Kulle B, Becker H, Goldenberg DM. Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann Surg Oncol 2007;14:2577-90. [PMID: 17570017 DOI: 10.1245/s10434-006-9328-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
31 Razafindratsira T, Isambert M, Evrard S. Complications of intraoperative radiofrequency ablation of liver metastases. HPB (Oxford). 2011;13:15-23. [PMID: 21159099 DOI: 10.1111/j.1477-2574.2010.00243.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
32 Okumura S, Tabchouri N, Leung U, Tinguely P, Louvet C, Beaussier M, Gayet B, Fuks D. Laparoscopic Parenchymal-Sparing Hepatectomy for Multiple Colorectal Liver Metastases Improves Outcomes and Salvageability: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2019;26:4576-4586. [PMID: 31605335 DOI: 10.1245/s10434-019-07902-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
33 Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125-135. [PMID: 18156932 DOI: 10.1097/sla.0b013e31815aa2c2] [Cited by in Crossref: 705] [Cited by in F6Publishing: 307] [Article Influence: 50.4] [Reference Citation Analysis]
34 Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol 2021;28:1457-65. [PMID: 33393036 DOI: 10.1245/s10434-020-09459-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Goldner M, Platoff R, Betances A, De Leo N, Gaughan J, Hageboutros A, Atabek U, Spitz FR, Hong YK. Role of metastasectomy for liver metastasis in stage IV anal cancer. Am J Surg 2021;221:832-8. [PMID: 32883493 DOI: 10.1016/j.amjsurg.2020.08.016] [Reference Citation Analysis]
36 Fuchshuber P, Petrelli N. A critical appraisal: providing care for patients with solid tumors metastases--challenges across academic and community practice. Surg Oncol Clin N Am 2007;16:695-701. [PMID: 17606202 DOI: 10.1016/j.soc.2007.04.006] [Reference Citation Analysis]
37 Lee BC, Lee HG, Park IJ, Kim SY, Kim KH, Lee JH, Kim CW, Lee JL, Yoon YS, Lim SB, Yu CS, Kim JC. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) 2016;95:e4999. [PMID: 27684857 DOI: 10.1097/MD.0000000000004999] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
38 Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013;7:1-6. [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
39 Yang AD, Brouquet A, Vauthey JN. Extending limits of resection for metastatic colorectal cancer: Risk benefit ratio: Resectability of Colorectal Liver Metastases. J Surg Oncol 2010;102:996-1001. [DOI: 10.1002/jso.21701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
40 Bower M, Wunderlich C, Brown R, Scoggins CR, Mcmasters KM, Martin RC. Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis. The American Journal of Surgery 2013;205:685-90. [DOI: 10.1016/j.amjsurg.2012.07.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbalisike E, Burkhard T, Zangos S. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014;119:451-461. [PMID: 24894923 DOI: 10.1007/s11547-014-0415-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
42 Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey J. Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection. J Gastrointest Surg 2017;21:628-35. [DOI: 10.1007/s11605-016-3324-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
43 Hong CW, Chow L, Turkbey EB, Lencioni R, Libutti SK, Wood BJ. Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors. Cardiovasc Intervent Radiol 2016;39:409-16. [PMID: 26228246 DOI: 10.1007/s00270-015-1186-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Eisele RM, Neumann U, Neuhaus P, Schumacher G. Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg. 2009;33:804-811. [PMID: 19184639 DOI: 10.1007/s00268-008-9905-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
45 Chun YS, Vauthey JN. Local Therapy for Colorectal Liver Metastases: Establishing Today's Level of Evidence and Defining Tomorrow's Roadmap. J Natl Cancer Inst 2017;109. [PMID: 28376150 DOI: 10.1093/jnci/djx018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Rempp H, Boss A, Helmberger T, Pereira P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging. 2011;36:635-647. [PMID: 21562884 DOI: 10.1007/s00261-011-9749-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
47 McKay A, Fradette K, Lipschitz J. Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases. HPB Surg 2009;2009:346863. [PMID: 20148084 DOI: 10.1155/2009/346863] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
48 Lam M, Loree JM, Pereira AAL, Chun YS, Kopetz S. Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer. Curr Treat Options Oncol 2018;19:11. [PMID: 29488033 DOI: 10.1007/s11864-018-0524-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
49 Brouquet A, Andreou A, Vauthey JN. The management of solitary colorectal liver metastases. Surgeon 2011;9:265-72. [PMID: 21843821 DOI: 10.1016/j.surge.2010.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
50 Wen J, Ye F, Xie F, Liu D, Huang L, Fang C, Zhong S, Ren L. The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment. Cancer Med 2020;9:4656-66. [PMID: 32396284 DOI: 10.1002/cam4.3117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G, Abraha I. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317. [PMID: 22696357 DOI: 10.1002/14651858.cd006317.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
52 Shah SA, Bromberg R, Coates A, Rempel E, Simunovic M, Gallinger S. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 2007;205:676-83. [PMID: 17964443 DOI: 10.1016/j.jamcollsurg.2007.06.283] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
53 Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg. 2010;210:934-941. [PMID: 20510802 DOI: 10.1016/j.jamcollsurg.2010.02.039] [Cited by in Crossref: 176] [Cited by in F6Publishing: 139] [Article Influence: 14.7] [Reference Citation Analysis]
54 Takeda A, Sanuki N, Kunieda E. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol 2014; 20(15): 4220-4229 [PMID: 24764660 DOI: 10.3748/wjg.v20.i15.4220] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
55 Fossum CC, Alabbad JY, Romak LB, Hallemeier CL, Haddock MG, Huebner M, Dozois EJ, Larson DW. The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis. J Gastrointest Oncol 2017;8:650-8. [PMID: 28890815 DOI: 10.21037/jgo.2017.06.07] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
56 Agas RAF, Co LBA, Jacinto JKM, Yu KKL, Sogono PG, Bacorro WR, Sy Ortin TT. Neoadjuvant Radiotherapy Versus No Radiotherapy for Stage IV Rectal Cancer: a Systematic Review and Meta-analysis. J Gastrointest Canc 2018;49:389-401. [DOI: 10.1007/s12029-018-0141-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Liu X, Xu D, Liu Z, Li Y, Zhang C, Gong Y, Jiang Y, Xing B. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition. Clin Transl Oncol 2020;22:1730-40. [PMID: 32052380 DOI: 10.1007/s12094-020-02308-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
58 Lendoire J, Moro M, Andriani O, Grondona J, Gil O, Raffin G, Silva J, Bracco R, Podestá G, Valenzuela C. Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford). 2007;9:435-439. [PMID: 18345290 DOI: 10.1080/13651820701769701] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
59 Rempp H, Waibel L, Hoffmann R, Claussen CD, Pereira PL, Clasen S. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol 2012;22:1972-82. [DOI: 10.1007/s00330-012-2438-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
60 Boleslawski E, Dharancy S, Truant S, Pruvot FR. Surgical management of liver metastases from gastrointestinal endocrine tumors. Gastroenterol Clin Biol 2010;34:274-82. [PMID: 20347242 DOI: 10.1016/j.gcb.2010.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol. 2008;15:2757-2764. [PMID: 18618182 DOI: 10.1245/s10434-008-0043-7] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 7.4] [Reference Citation Analysis]
62 Yamakado K, Inaba Y, Sato Y, Yasumoto T, Hayashi S, Yamanaka T, Nobata K, Takaki H, Nakatsuka A. Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study. Cardiovasc Intervent Radiol. 2017;40:560-567. [PMID: 27999917 DOI: 10.1007/s00270-016-1547-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
63 Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer. 2009;45:1748-1756. [PMID: 19356924 DOI: 10.1016/j.ejca.2009.03.012] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
64 Chen S, Li YF, Feng XY, Zhou ZW, Yuan XH, Chen YB. Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol. 2012;106:862-871. [PMID: 22648960 DOI: 10.1002/jso.23158] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
65 Kurbatov V, Resio BJ, Cama CA, Heller DR, Cha C, Zhang Y, Lu J, Khan SA. Liver-first approach to stage IV colon cancer with synchronous isolated liver metastases. J Gastrointest Oncol 2020;11:76-83. [PMID: 32175108 DOI: 10.21037/jgo.2020.01.03] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Cannon RM, Brown RE, Hill CR, Dunki-jacobs E, Martin RCG, Mcmasters KM, Scoggins CR. Negative Effects of Transfused Blood Components after Hepatectomy for Metastatic Colorectal Cancer. The American Surgeon 2013;79:35-9. [DOI: 10.1177/000313481307900120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
67 Scafa D, Muedder T, Holz JA, Koch D, Nour Y, Garbe S, Gonzalez-Carmona MA, Feldmann G, Vilz TO, Köksal M, Giordano FA, Schmeel LC, Sarria GR. Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases. Front Oncol 2021;11:767468. [PMID: 34926271 DOI: 10.3389/fonc.2021.767468] [Reference Citation Analysis]
68 Bennett S, Søreide K, Gholami S, Pessaux P, Teh C, Segelov E, Kennecke H, Prenen H, Myrehaug S, Callegaro D, Hallet J. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 2020;27:e501-11. [PMID: 33173390 DOI: 10.3747/co.27.6785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol. 2010;19:e22-e32. [PMID: 19268571 DOI: 10.1016/j.suronc.2009.02.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 6.5] [Reference Citation Analysis]
70 Abdel-Misih SR, Schmidt CR, Bloomston PM. Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol 2009;7:72. [PMID: 19788748 DOI: 10.1186/1477-7819-7-72] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
71 Han Y, Yan D, Xu F, Li X, Cai JQ. Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) 2016;129:2983-90. [PMID: 27958231 DOI: 10.4103/0366-6999.195470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
72 Boone BA, Bartlett DL, Zureikat AH. Isolated Hepatic Perfusion for the Treatment of Liver Metastases. Current Problems in Cancer 2012;36:27-76. [DOI: 10.1016/j.currproblcancer.2011.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
73 Long D, Yu PC, Huang W, Luo YL, Zhang S. Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer. Medicine (Baltimore) 2016;95:e5235. [PMID: 27858875 DOI: 10.1097/MD.0000000000005235] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011; 17(36): 4143-4148 [PMID: 22039331 DOI: 10.3748/wjg.v17.i36.4143] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
75 Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008;12:1967-1972. [PMID: 18688683 DOI: 10.1007/s11605-008-0622-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
76 Venkat SR, Mohan PP, Gandhi RT. Colorectal Liver Metastasis: Overview of Treatment Paradigm Highlighting the Role of Ablation. American Journal of Roentgenology 2018;210:883-90. [DOI: 10.2214/ajr.17.18574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
77 Lee JH, Lee JH, Jang HS, Lee HC, Lee JW, Kang DG, Shim BY, Kye B, Kim HJ, Cho H, Suh YJ, Kim SH. Hypofractionated radiotherapy with Tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions. Clin Exp Metastasis 2013;30:643-50. [DOI: 10.1007/s10585-013-9568-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
78 Hammill CW, Billingsley KG, Cassera MA, Wolf RF, Ujiki MB, Hansen PD. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol. 2011;18:1947-1954. [PMID: 21399885 DOI: 10.1245/s10434-010-1535-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
79 Apers T, Hendrikx B, Bracke B, Hartman V, Roeyen G, Ysebaert D, Op de Beeck B, Chapelle T. Parenchymal-sparing hepatectomy with hepatic vein resection and reconstruction. Acta Chir Belg 2021;:1-7. [PMID: 33860723 DOI: 10.1080/00015458.2021.1915021] [Reference Citation Analysis]
80 Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Current perioperative outcomes for patients with disseminated cancer. J Surg Res 2015;197:118-25. [PMID: 25911950 DOI: 10.1016/j.jss.2015.03.063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
81 Ihemelandu C, Levine EA, Aklilu M, Yacoub G, Howerton R, Bolemon B, Graham M, Russell G, Shen P. Optimal Timing of Systemic Therapy in Resectable Colorectal Liver Metastases. The American Surgeon 2013;79:414-21. [DOI: 10.1177/000313481307900432] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 King AJ, Breen DJ. Understanding the current status of image-guided ablation for metastatic colorectal disease. Abdom Imaging 2013;38:1234-44. [PMID: 23764908 DOI: 10.1007/s00261-013-0020-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
83 Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS; World Consensus Conference on Laparoscopic Surgery. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 2009;250:825-30. [PMID: 19916210 DOI: 10.1097/sla.0b013e3181b3b2d8] [Cited by in Crossref: 969] [Cited by in F6Publishing: 375] [Article Influence: 74.5] [Reference Citation Analysis]
84 Halpern AL, Fitz JG, Fujiwara Y, Yi J, Anderson AL, Zhu Y, Schulick RD, El Kasmi KC, Barnett CC Jr. Hepatic thermal injury promotes colorectal cancer engraftment in C57/black 6 mice. Am J Physiol Cell Physiol 2021;320:C142-51. [PMID: 33175574 DOI: 10.1152/ajpcell.00071.2020] [Reference Citation Analysis]
85 Schiffman SC, Bower M, Brown RE, Martin RC, McMasters KM, Scoggins CR. Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg. 2010;14:1881-1886; discussion 1886-1887. [PMID: 20859701 DOI: 10.1007/s11605-010-1339-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
86 Yoon HM, Kim JH, Shin YM, Won HJ, Kim PN. Percutaneous radiofrequency ablation using internally cooled wet electrodes for treatment of colorectal liver metastases. Clin Radiol. 2012;67:122-127. [PMID: 21906730 DOI: 10.1016/j.crad.2011.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
87 Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51-64. [PMID: 18245012 DOI: 10.1634/theoncologist.2007-0142] [Cited by in Crossref: 290] [Cited by in F6Publishing: 263] [Article Influence: 20.7] [Reference Citation Analysis]
88 Schoellhammer HF, Goldner B, Merchant SJ, Kessler J, Fong Y, Gagandeep S. Colorectal liver metastases: making the unresectable resectable using irreversible electroporation for microscopic positive margins - a case report. BMC Cancer 2015;15:271. [PMID: 25886376 DOI: 10.1186/s12885-015-1279-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
89 Lu F, Poruk KE, Weiss MJ. Surgery for oligometastasis of pancreatic cancer. Chin J Cancer Res. 2015;27:358-367. [PMID: 26361405 DOI: 10.3978/j.issn.1000-9604.2015.05.02] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
90 Abdalla EK. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol. 2010;102:960-967. [PMID: 21165999 DOI: 10.1002/jso.21654] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
91 Huang J, Li Q, Zheng Y, Shen J, Li B, Zou R, Wang J, Yuan Y. Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature. BMC Cancer 2014;14:818. [PMID: 25376591 DOI: 10.1186/1471-2407-14-818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
92 Hur H, Ko YT, Min BS, Kim KS, Choi JS, Sohn SK, Cho CH, Ko HK, Lee JT, Kim NK. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg. 2009;197:728-736. [PMID: 18789428 DOI: 10.1016/j.amjsurg.2008.04.013] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 10.4] [Reference Citation Analysis]
93 Adam R, Hoti E, Bredt LC. [Oncosurgical strategies for metastatic liver cancer]. Cir Esp 2011;89:10-9. [PMID: 21176894 DOI: 10.1016/j.ciresp.2010.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
94 Zhang K, Yu J, Zhou F, Yu X, Li X, Wang J, Han Z, Cheng Z, Liang P. Impact of timing and cycles of systemic chemotherapy on survival outcome of colorectal liver metastases patients treated by percutaneous microwave ablation. International Journal of Hyperthermia 2016;32:531-8. [DOI: 10.3109/02656736.2016.1156169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
95 Malik HZ. The case for neo-adjuvant chemotherapy. For. Ann R Coll Surg Engl 2008;90:452-4. [PMID: 18777621 DOI: 10.1308/003588408X321620] [Reference Citation Analysis]
96 Cheon S, Rha S, Jeung H, Im C, Kim S, Kim H, Ahn J, Roh J, Noh S, Chung H. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Annals of Oncology 2008;19:1146-53. [DOI: 10.1093/annonc/mdn026] [Cited by in Crossref: 116] [Cited by in F6Publishing: 114] [Article Influence: 8.3] [Reference Citation Analysis]
97 Hao W, Binbin J, Wei Y, Kun Y. Can Radiofrequency Ablation Replace Liver Resection for Solitary Colorectal Liver Metastasis? A Systemic Review and Meta-Analysis. Front Oncol 2020;10:561669. [PMID: 33312946 DOI: 10.3389/fonc.2020.561669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Westover KD, Iyengar P, Sharma AN, Timmerman R. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer. Lung Cancer 2015;89:87-93. [PMID: 26028304 DOI: 10.1016/j.lungcan.2015.04.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
99 Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007;17:2062-70. [PMID: 17429644 DOI: 10.1007/s00330-007-0587-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
100 He N, Jin QN, Wang D, Yang YM, Liu YL, Wang GB, Tao KX. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technolog Med Sci. 2016;36:514-518. [PMID: 27465325 DOI: 10.1007/s11596-016-1617-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Dilling TJ, Hoffe SE. Stereotactic body radiation therapy: transcending the conventional to improve outcomes. Cancer Control 2008;15:104-11. [PMID: 18376377 DOI: 10.1177/107327480801500202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
102 Srinivasan S, Yee NA, Wu K, Zakharian M, Mahmoodi A, Royzen M, Oneto JMM. SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions. Adv Ther (Weinh) 2021;4:2000243. [PMID: 33869738 DOI: 10.1002/adtp.202000243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Brachet D, Lermite E, Rouquette A, Lorimier G, Hamy A, Arnaud JP. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum. 2009;52:475-483. [PMID: 19333049 DOI: 10.1007/dcr.0b013e31819d12bc] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
104 Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301. [PMID: 23152705 DOI: 10.2147/clep.s34285] [Cited by in Crossref: 67] [Cited by in F6Publishing: 154] [Article Influence: 6.7] [Reference Citation Analysis]
105 Acciuffi S, Meyer F, Bauschke A, Croner R, Settmacher U, Altendorf-Hofmann A. Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors. J Cancer Res Clin Oncol 2021. [PMID: 34914005 DOI: 10.1007/s00432-021-03880-4] [Reference Citation Analysis]
106 Maingon P, Nouhaud É, Mornex F, Créhange G. Stereotactic body radiation therapy for liver tumours. Cancer/Radiothérapie 2014;18:313-9. [DOI: 10.1016/j.canrad.2014.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
107 Gavriilidis P, Roberts KJ, de'Angelis N, Aldrighetti L, Sutcliffe RP. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int 2021;20:307-14. [PMID: 34127382 DOI: 10.1016/j.hbpd.2021.05.004] [Reference Citation Analysis]
108 Basler L, Kroeze SG, Guckenberger M. SBRT for oligoprogressive oncogene addicted NSCLC. Lung Cancer 2017;106:50-7. [PMID: 28285694 DOI: 10.1016/j.lungcan.2017.02.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
109 Saiura A, Yamamoto J, Koga R, Kokudo N, Seki M, Oya M, Ueno M, Kuroyanagi H, Fujimoto Y, Natori T, Yamaguchi T, Muto T. Outcome after hepatic resection of solitary liver metastasis from colorectal cancer in the caudate lobe. World J Surg 2007;31:2378-83. [PMID: 17912586 DOI: 10.1007/s00268-007-9250-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
110 Day RW, Aloia TA. Enhanced recovery in liver surgery. J Surg Oncol 2019;119:660-6. [PMID: 30802314 DOI: 10.1002/jso.25420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
111 Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM, Martin RC. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol. 2009;16:35-41. [PMID: 18987915 DOI: 10.1245/s10434-008-0190-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
112 Snoeren N, Voest EE, Bergman AM, Dalesio O, Verheul HM, Tollenaar RA, van der Sijp JR, Schouten SB, Rinkes IH, van Hillegersberg R. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. BMC Cancer. 2010;10:545. [PMID: 20937118 DOI: 10.1186/1471-2407-10-545] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
113 Wood BJ, Poon RT, Locklin JK, Dreher MR, Ng KK, Eugeni M, Seidel G, Dromi S, Neeman Z, Kolf M, Black CD, Prabhakar R, Libutti SK. Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol 2012;23:248-55.e7. [PMID: 22178041 DOI: 10.1016/j.jvir.2011.10.018] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 8.1] [Reference Citation Analysis]
114 Evrard S. [Intraoperative radiofrequency ablation of liver metastases: age of reason]. Bull Cancer 2010;97:91-6. [PMID: 20007068 DOI: 10.1684/bdc.2009.1018] [Reference Citation Analysis]
115 Anker CJ, Wo JY. Personalized Medicine in Radiation Oncology—A Work in Progress. International Journal of Radiation Oncology*Biology*Physics 2015;92:843-5. [DOI: 10.1016/j.ijrobp.2015.04.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
116 Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC. Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol 2011;2011:686030. [PMID: 22312518 DOI: 10.1155/2011/686030] [Reference Citation Analysis]
117 Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, Sobrero A, Ychou M; European Colorectal Metastases Treatment Group; Sixth International Colorectal Liver Metastases Workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol. 2009;20:985-992. [PMID: 19153115 DOI: 10.1093/annonc/mdn735] [Cited by in Crossref: 243] [Cited by in F6Publishing: 209] [Article Influence: 18.7] [Reference Citation Analysis]
118 Li XF, Tan YN, Zhong CH, Zhu LZ, Fang XF, Li J, Ding KF, Yuan Y. Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery. Oncotarget 2017;8:79618-28. [PMID: 29108341 DOI: 10.18632/oncotarget.18896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
119 Takeda A, Sanuki N, Tsurugai Y, Oku Y, Aoki Y. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions. J Radiat Res 2016;57:400-5. [PMID: 26983981 DOI: 10.1093/jrr/rrw029] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
120 Gunvén P, Jonas E, Wersäll P, Lax I. Surgical displacement of risk organs to improve stereotactic radiotherapy for liver tumors. J Surg Oncol 2009;100:515-7. [PMID: 19653246 DOI: 10.1002/jso.21366] [Reference Citation Analysis]
121 Chin K, Mangat K. Radiofrequency ablation of colorectal liver metastases in a transplanted liver. Cardiovasc Intervent Radiol 2009;32:1114-6. [PMID: 19504153 DOI: 10.1007/s00270-009-9611-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493-508. [PMID: 19841322 DOI: 10.1200/jco.2009.23.4450] [Cited by in Crossref: 305] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
123 Benhaim L, El Hajjam M, Malafosse R, Sellier J, Julie C, Beauchet A, Nordlinger B, Peschaud F. Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression. HPB 2018;20:76-82. [DOI: 10.1016/j.hpb.2017.08.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
124 Reddy SK, Barbas AS, Clary BM. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol. 2009;16:2395-2410. [PMID: 19506963 DOI: 10.1245/s10434-009-0372-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
125 Saxena A, Chua TC, Chu FC, Ng KM, Herle P, Morris DL. Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases. J Gastrointest Oncol 2014;5:46-56. [PMID: 24490042 DOI: 10.3978/j.issn.2078-6891.2013.055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Cannon RM, Martin RC, Callender GG, McMasters KM, Scoggins CR. Safety and efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol 2011;104:804-8. [PMID: 21792943 DOI: 10.1002/jso.22042] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
127 Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng H, Wang Z, Xu Y. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol 2016;14:289. [PMID: 27852294 DOI: 10.1186/s12957-016-1044-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
128 Gillams AR, Lees WR. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol. 2008;19:712-717. [PMID: 18440460 DOI: 10.1016/j.jvir.2008.01.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
129 Devun F, Biau J, Huerre M, Croset A, Sun JS, Denys A, Dutreix M. Colorectal cancer metastasis: the DNA repair inhibitor Dbait increases sensitivity to hyperthermia and improves efficacy of radiofrequency ablation. Radiology. 2014;270:736-746. [PMID: 24475822 DOI: 10.1148/radiol.13130805] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
130 Khan AZ, Wong VK, Malik HZ, Stiff GM, Prasad KR, Lodge JP, Toogood GJ. The impact of caudate lobe involvement after hepatic resection for colorectal metastases. Eur J Surg Oncol 2009;35:510-4. [PMID: 18644694 DOI: 10.1016/j.ejso.2008.06.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
131 Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D, Abdalla EK, Choti MA, Kemp C, Vauthey JN. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol. 2009;16:1809-1819. [PMID: 18979139 DOI: 10.1245/s10434-008-0181-y] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
132 Zheng JH, Chang ZH, Liu ZY, Lu ZM, Guo QY. 125I radioactive seed interstitial brachytherapy for liver metastases. Shijie Huaren Xiaohua Zazhi 2011; 19(31): 3264-3267 [DOI: 10.11569/wcjd.v19.i31.3264] [Reference Citation Analysis]
133 Hamada A, Yamakado K, Nakatsuka A, Uraki J, Kashima M, Takaki H, Yamanaka T, Inoue Y, Kusunoki M, Takeda K. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Jpn J Radiol. 2012;30:567-574. [PMID: 22664831 DOI: 10.1007/s11604-012-0089-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
134 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
135 Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One 2016;11:e0165315. [PMID: 27780274 DOI: 10.1371/journal.pone.0165315] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
136 Hassanain M, Al-Alem F, Simoneau E, Traiki TA, Alsaif F, Alsharabi A, Al-Faris H, Al-Saleh K. Colorectal cancer liver metastasis trends in the kingdom of Saudi Arabia. Saudi J Gastroenterol 2016;22:370-4. [PMID: 27748323 DOI: 10.4103/1319-3767.191142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
137 Abbott DE, Sohn VY, Hanseman D, Curley SA. Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases. J Surg Oncol 2014;109:516-20. [PMID: 24374772 DOI: 10.1002/jso.23539] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
138 Lim E, Thomson BN, Heinze S, Chao M, Gunawardana D, Gibbs P. Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer. ANZ J Surg 2007;77:941-7. [PMID: 17931254 DOI: 10.1111/j.1445-2197.2007.04287.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
139 Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968-974. [PMID: 21166000 DOI: 10.1002/jso.21720] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
140 Xu D, Liu XF, Yan XL, Wang K, Xing BC. Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy. Oncol Lett 2017;14:8051-9. [PMID: 29344248 DOI: 10.3892/ol.2017.7191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
141 Kulaylat MN, Gibbs JF. Thermoablation of colorectal liver metastasis. J Surg Oncol 2010;101:699-705. [PMID: 20512946 DOI: 10.1002/jso.21504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
142 Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow H, Duckworth A, Heister P, Praseedom R, Jah A, Balakrishnan A, Harper S, Liau S, Kosmoliaptsis V, Huguet E. Colorectal liver metastases: Current management and future perspectives. World J Clin Oncol 2020; 11(10): 761-808 [PMID: 33200074 DOI: 10.5306/wjco.v11.i10.761] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
143 Gruber-Rouh T, Marko C, Thalhammer A, Nour-Eldin NE, Langenbach M, Beeres M, Naguib NN, Zangos S, Vogl TJ. Current strategies in interventional oncology of colorectal liver metastases. Br J Radiol. 2016;26:20151060. [PMID: 27164030 DOI: 10.1259/bjr.20151060] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
144 Passot G, Vauthey JN. In favor of two-stage hepatectomy (TSH). Eur J Surg Oncol 2015;41:1566-7. [PMID: 26409952 DOI: 10.1016/j.ejso.2015.08.169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
145 Kim HR, Cheon SH, Lee KH, Ahn JR, Jeung HC, Lee SS, Chung HC, Noh SH, Rha SY. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma. Int J Hyperthermia. 2010;26:305-315. [PMID: 20210605 DOI: 10.3109/02656730903555696] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
146 Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014; 20(35): 12391-12406 [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
147 Conde-Moreno AJ, Lopez-Guerra JL, Macias VA, Vázquez de la Torre ML, Samper Ots P, San José-Maderuelo S, Pastor Peidro J, López-Torrecilla J, Expósito-Hernández J. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases. Clin Transl Oncol 2016;18:342-51. [PMID: 26329294 DOI: 10.1007/s12094-015-1383-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
148 Cagel M, Grotz E, Bernabeu E, Moretton MA, Chiappetta DA. Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discovery Today 2017;22:270-81. [DOI: 10.1016/j.drudis.2016.11.005] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 28.8] [Reference Citation Analysis]
149 Lee CW, Kim JH, Won HJ, Shin YM, Ko HK, Kim PN, Ryu MH. Percutaneous Radiofrequency Ablation of Hepatic Metastases from Gastric Adenocarcinoma after Gastrectomy. J Vasc Interv Radiol 2015;26:1172-9. [PMID: 26116362 DOI: 10.1016/j.jvir.2015.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
150 Brown RE, Bower MR, Martin RC. Hepatic resection for colorectal liver metastases. Surg Clin North Am. 2010;90:839-852. [PMID: 20637951 DOI: 10.1016/j.suc.2010.04.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
151 Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009;27:1572-1578. [PMID: 19255321 DOI: 10.1200/jco.2008.19.6329] [Cited by in Crossref: 560] [Cited by in F6Publishing: 232] [Article Influence: 43.1] [Reference Citation Analysis]
152 Fong Y, Wong J. Evolution in surgery: influence of minimally invasive approaches on the hepatobiliary surgeon. Surg Infect (Larchmt) 2009;10:399-406. [PMID: 19943774 DOI: 10.1089/sur.2009.9936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
153 Ikoma N, You YN, Bednarski BK, Rodriguez-Bigas MA, Eng C, Das P, Kopetz S, Messick C, Skibber JM, Chang GJ. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol 2017;35:2631-8. [PMID: 28657814 DOI: 10.1200/JCO.2016.72.1464] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
154 McGrane S, McSweeney SE, Maher MM. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging. 2008;33:48-53. [PMID: 17874263 DOI: 10.1007/s00261-007-9313-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
155 Neri F, Ercolani G, Di Gioia P, Del Gaudio M, Pinna AD. Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. Updates Surg 2015;67:223-33. [PMID: 26341625 DOI: 10.1007/s13304-015-0315-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
156 Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cardiovasc Intervent Radiol. 2018;41:1189-1204. [PMID: 29666906 DOI: 10.1007/s00270-018-1959-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 15.8] [Reference Citation Analysis]
157 Aliyev S, Agcaoglu O, Aksoy E, Taskin HE, Vogt D, Fung J, Siperstein A, Berber E. Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery. 2013;154:556-562. [PMID: 23859307 DOI: 10.1016/j.surg.2013.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
158 Park JY, Murakami T, Lee JY, Zhang Y, Hoffman RM, Bouvet M. Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models. PLoS One 2016;11:e0146504. [PMID: 26731105 DOI: 10.1371/journal.pone.0146504] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
159 Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19:1206-1213. [PMID: 19137310 DOI: 10.1007/s00330-008-1258-5] [Cited by in Crossref: 168] [Cited by in F6Publishing: 157] [Article Influence: 12.9] [Reference Citation Analysis]
160 Lau KN, Swan RZ, Sindram D, Martinie JB, Iannitti DA. Hepatic tumor ablation: application in a community hospital setting. Surg Oncol Clin N Am 2011;20:455-66, viii. [PMID: 21640915 DOI: 10.1016/j.soc.2011.01.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Akgül Ö, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol. 2014;20:6113-6122. [PMID: 24876733 DOI: 10.3748/wjg.v20.i20.6113.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Beaty KA, Curley SA. Metastectomy for combined hepatic and extrahepatic colorectal cancer metastases. Curr colorectal cancer rep 2007;3:89-93. [DOI: 10.1007/s11888-007-0006-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
163 Kim H, Gill B, Beriwal S, Huq MS, Roberts MS, Smith KJ. Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases. International Journal of Radiation Oncology*Biology*Physics 2016;95:1175-83. [DOI: 10.1016/j.ijrobp.2016.02.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
164 Acciuffi S, Meyer F, Bauschke A, Settmacher U, Lippert H, Croner R, Altendorf-Hofmann A. Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study. J Cancer Res Clin Oncol. 2018;144:593-599. [PMID: 29340767 DOI: 10.1007/s00432-018-2583-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
165 Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC, Clary BM. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg. 2007;204:372-382. [PMID: 17324770 DOI: 10.1016/j.jamcollsurg.2006.12.019] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
166 Tanaka T, Isfort P, Braunschweig T, Westphal S, Woitok A, Penzkofer T, Bruners P, Kichikawa K, Schmitz-Rode T, Mahnken AH. Superselective particle embolization enhances efficacy of radiofrequency ablation: effects of particle size and sequence of action. Cardiovasc Intervent Radiol. 2013;36:773-782. [PMID: 23070107 DOI: 10.1007/s00270-012-0497-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
167 Yang G, Wang G, Sun J, Xiong Y, Li W, Tang T, Li J. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Int J Surg 2021;87:105896. [PMID: 33588125 DOI: 10.1016/j.ijsu.2021.105896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Abdalla EK. Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. Am J Surg. 2009;197:737-739. [PMID: 18789420 DOI: 10.1016/j.amjsurg.2008.06.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
169 van der Pool AE, Méndez Romero A, Wunderink W, Heijmen BJ, Levendag PC, Verhoef C, Ijzermans JN. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg. 2010;97:377-382. [PMID: 20095016 DOI: 10.1002/bjs.6895] [Cited by in Crossref: 108] [Cited by in F6Publishing: 92] [Article Influence: 9.0] [Reference Citation Analysis]
170 Bresadola V, Rossetto A, Adani GL, Baccarani U, Lorenzin D, Favero A, Bresadola F. Liver resection for noncolorectal and nonneuroendocrine metastases: Results of a study on 56 patients at a single institution. Tumori 2011;97:316-22. [DOI: 10.1177/030089161109700310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
171 Khatri VP, Chee KG, Petrelli NJ. Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 2007;16:71-83. [PMID: 17532622 DOI: 10.1016/j.suronc.2007.05.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
172 Delabrousse E, Mithieux F, Birer A, Chesnais S, Salomir R, Chapelon J, Lafon C. Percutaneous Sonographically Guided Interstitial US Ablation: Experimentation in an In Vivo Pig Liver Model. Journal of Vascular and Interventional Radiology 2008;19:1749-56. [DOI: 10.1016/j.jvir.2008.09.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
173 Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC. Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis. Journal of the American College of Surgeons 2012;214:769-77. [DOI: 10.1016/j.jamcollsurg.2011.12.048] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
174 Doughtie CA, Egger ME, Cannon RM, Martin RCG, Mcmasters KM, Scoggins CR. Laparoscopic Hepatectomy is a Safe and Effective Approach for Resecting Large Colorectal Liver Metastases. The American Surgeon 2013;79:566-71. [DOI: 10.1177/000313481307900615] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
175 Oliver DE, Mohammadi H, Figura N, Frakes JM, Yamoah K, Perez BA, Wuthrick EJ, Naghavi AO, Caudell JJ, Harrison LB, Torres-roca JF, Ahmed KA. Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy. Seminars in Radiation Oncology 2019;29:111-25. [DOI: 10.1016/j.semradonc.2018.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
176 Wild AT, Yamada Y. Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer. Visc Med 2017;33:54-61. [PMID: 28612018 DOI: 10.1159/000454685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
177 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
178 Gravante G, Overton J, Sorge R, Bhardwaj N, Metcalfe MS, Lloyd DM, Dennison AR. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15:378-387. [PMID: 21061179 DOI: 10.1007/s11605-010-1377-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
179 Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Radiology 2009;253:861-9. [PMID: 19709994 DOI: 10.1148/radiol.2533081968] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 6.4] [Reference Citation Analysis]
180 Worni M, Shah KN, Clary BM. Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. Curr Oncol Rep. 2014;16:407. [PMID: 25129331 DOI: 10.1007/s11912-014-0407-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
181 Kron P, Linecker M, Jones RP, Toogood GJ, Clavien PA, Lodge JPA. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front Oncol. 2019;9:1052. [PMID: 31750233 DOI: 10.3389/fonc.2019.01052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
182 Chakedis J, Squires MH, Beal EW, Hughes T, Lewis H, Paredes A, Al-Mansour M, Sun S, Cloyd JM, Pawlik TM. Update on current problems in colorectal liver metastasis. Curr Probl Surg. 2017;54:554-602. [PMID: 29198365 DOI: 10.1067/j.cpsurg.2017.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
183 Jin H, Chalkidou A, Hawkins M, Summers J, Eddy S, Peacock JL, Coker B, Kartha MR, Good J, Pennington M; SABR Data Working Group. Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiation Therapy Compared With Surgery and Radiofrequency Ablation in Two Patient Cohorts: Metastatic Liver Cancer and Hepatocellular Carcinoma. Clin Oncol (R Coll Radiol) 2021;33:e143-54. [PMID: 32951952 DOI: 10.1016/j.clon.2020.08.010] [Reference Citation Analysis]
184 Reuter NP, Woodall CE, Scoggins CR, Mcmasters KM, Martin RCG. Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent? J Gastrointest Surg 2009;13:486-91. [DOI: 10.1007/s11605-008-0727-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
185 Flanders VL, Gervais DA. Ablation of Liver Metastases: Current Status. Journal of Vascular and Interventional Radiology 2010;21:S214-22. [DOI: 10.1016/j.jvir.2010.01.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
186 Shah NK, Yegya-Raman N, Jones JA, Shabason JE. Radiation Therapy in Metastatic Soft Tissue Sarcoma: From Palliation to Ablation. Cancers (Basel) 2021;13:4775. [PMID: 34638260 DOI: 10.3390/cancers13194775] [Reference Citation Analysis]
187 Ko S, Jo H, Yun S, Park E, Kim S, Seo HI. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol 2014; 20(2): 525-531 [PMID: 24574721 DOI: 10.3748/wjg.v20.i2.525] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
188 Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 2011;98:1003-9. [PMID: 21541936 DOI: 10.1002/bjs.7506] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
189 Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tomé WA, Ten Haken RK, Ohri N, Méndez Romero A, Goodman KA, Marks LB, Kavanagh B, Dawson LA. Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys 2021;110:196-205. [PMID: 29482870 DOI: 10.1016/j.ijrobp.2017.12.290] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
190 Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS, Gamblin TC. Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford) 2013;15:365-71. [PMID: 23458599 DOI: 10.1111/j.1477-2574.2012.00585.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
191 Munene G, Parker RD, Shaheen AA, Myers RP, Quan ML, Ball CG, Dixon E. Disparities in the surgical treatment of colorectal liver metastases. J Natl Med Assoc 2013;105:128-37. [PMID: 24079213 DOI: 10.1016/s0027-9684(15)30112-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
192 Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, Ha HK, Kim JC. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011;81:25-34. [PMID: 22066097 DOI: 10.4174/jkss.2011.81.1.25] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
193 Tzeng CD, Aloia TA. Colorectal Liver Metastases. J Gastrointest Surg 2013;17:195-202. [DOI: 10.1007/s11605-012-2022-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
194 Page AJ, Cosgrove D, Pawlik TM. Comparative effectiveness in hepatic malignancies. Cancer Treat Res 2015;164:195-219. [PMID: 25677025 DOI: 10.1007/978-3-319-12553-4_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
195 Knab LM, Salem R, Mahvi DM. Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 2013;50:146-79. [PMID: 23507316 DOI: 10.1067/j.cpsurg.2013.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
196 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
197 de Jong KP. Review article: Multimodality treatment of liver metastases increases suitability for surgical treatment. Aliment Pharmacol Ther. 2007;26 Suppl 2:161-169. [PMID: 18081659 DOI: 10.1111/j.1365-2036.2007.03484.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
198 Verwaal VJ, Kusamura S, Baratti D, Deraco M. The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol. 2008;98:220-223. [PMID: 18726879 DOI: 10.1002/jso.21060] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
199 Mayo SC, Heckman JE, Shore AD, Nathan H, Parikh AA, Bridges JF, Anders RA, Anaya DA, Becker NS, Pawlik TM. Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery 2011;150:204-16. [PMID: 21801959 DOI: 10.1016/j.surg.2011.06.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
200 Ansari D, Bergenfeldt M, Tingstedt B, Andersson R. Multimodal management of colorectal liver metastases and the effect on regeneration and outcome after liver resection. Scand J Gastroenterol 2012;47:1460-6. [PMID: 23035803 DOI: 10.3109/00365521.2012.729083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
201 Helling TS, Martin M. Cause of death from liver metastases in colorectal cancer. Ann Surg Oncol. 2014;21:501-506. [PMID: 24081807 DOI: 10.1245/s10434-013-3297-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
202 Tohme S, Goswami J, Han K, Chidi AP, Geller DA, Reddy S, Gleisner A, Tsung A. Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery. J Gastrointest Surg 2015;19:2199-206. [PMID: 26438480 DOI: 10.1007/s11605-015-2962-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
203 Ou S, Xu R, Li K, Chen Y, Kong Y, Liu H, Li J, Ouyang Y, Yu X. Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study. Cancer Manag Res 2018;10:5227-37. [PMID: 30464620 DOI: 10.2147/CMAR.S170160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
204 Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, Hirokawa F, Taniai N, Watanabe M, Katou M, Nagano H, Honda G, Baba H, Kokudo N, Konishi M, Hirata K, Yamamoto M, Uchiyama K, Uchida E, Kusachi S, Kubota K, Mori M, Takahashi K, Kikuchi K, Miyata H, Takahara T, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, Takada T. Long-term and perioperative outcomes of laparoscopic vs open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22:711-720. [PMID: 25902703 DOI: 10.1002/jhbp.261] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 13.4] [Reference Citation Analysis]
205 Choi EA, Abdalla EK. Patient selection and outcome of hepatectomy for noncolorectal non-neuroendocrine liver metastases. Surg Oncol Clin N Am 2007;16:557-77, ix. [PMID: 17606194 DOI: 10.1016/j.soc.2007.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
206 de Baere T. Traitement des métastases hépatiques par radiofréquence. Cancer/Radiothérapie 2012;16:339-43. [DOI: 10.1016/j.canrad.2012.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
207 Berri RN, Abdalla EK. Curable metastatic colorectal cancer: recommended paradigms. Curr Oncol Rep 2009;11:200-8. [PMID: 19336012 DOI: 10.1007/s11912-009-0029-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
208 Wicherts DA, de Haas RJ, Andreani P, Ariche A, Salloum C, Pascal G, Castaing D, Adam R, Azoulay D. Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford). 2011;13:536-543. [PMID: 21762296 DOI: 10.1111/j.1477-2574.2011.00321.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
209 Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. [PMID: 25444471 DOI: 10.1016/j.soc.2014.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
210 Ahmed KA, Fulp WJ, Berglund AE, Hoffe SE, Dilling TJ, Eschrich SA, Shridhar R, Torres-Roca JF. Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection. Int J Radiat Oncol Biol Phys 2015;92:837-42. [PMID: 25838188 DOI: 10.1016/j.ijrobp.2015.01.036] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
211 Tsai S, Pawlik TM. Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges? Ann Surg Oncol 2009;16:2422-8. [PMID: 19554378 DOI: 10.1245/s10434-009-0491-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
212 Julianov A. Radiofrequency ablation or resection for small colorectal liver metastases - a plea for caution. Quant Imaging Med Surg 2013;3:63-6. [PMID: 23630652 DOI: 10.3978/j.issn.2223-4292.2013.04.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Camacho JC, Petre EN, Sofocleous CT. Thermal Ablation of Metastatic Colon Cancer to the Liver. Semin Intervent Radiol 2019;36:310-8. [PMID: 31680722 DOI: 10.1055/s-0039-1698754] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
214 Sun Z, Thacker JM. Contemporary Surgical Options for Metastatic Colorectal Cancer. Curr Oncol Rep 2015;17. [DOI: 10.1007/s11912-015-0437-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
215 Saiura A, Yamamoto J, Sakamoto Y, Koga R, Seki M, Kishi Y. Safety and efficacy of hepatic vein reconstruction for colorectal liver metastases. Am J Surg. 2011;202:449-454. [PMID: 21777900 DOI: 10.1016/j.amjsurg.2010.08.040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
216 Kawaguchi Y, Hasegawa K, Saiura A, Nagata R, Takahashi M, Oba M, Kaneko J, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N. Surgical resection for local recurrence after radiofrequency ablation for colorectal liver metastasis is more extensive than primary resection. Scand J Gastroenterol 2014;49:569-75. [PMID: 24625240 DOI: 10.3109/00365521.2014.893013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
217 Wang LJ, Zhang ZY, Yan XL, Yang W, Yan K, Xing BC. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. World J Surg Oncol 2018;16:207. [PMID: 30322402 DOI: 10.1186/s12957-018-1494-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
218 Jones EL, Halpern AL, Carmichael H, Wikiel KJ, Jones TS, Moore JT, Robinson TN, Barnett CC Jr. Hepatic Ablation Promotes Colon Cancer Metastases in an Immunocompetent Murine Model. Ann Surg 2019;270:675-80. [PMID: 31348044 DOI: 10.1097/SLA.0000000000003474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Singla S, Hochwald SN, Kuvshinoff B. Evolving ablative therapies for hepatic malignancy. Biomed Res Int 2014;2014:230174. [PMID: 24877069 DOI: 10.1155/2014/230174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
220 Resende Salgado L, Hsu H, Du K. Outcomes of rectal cancer with liver oligometastases. J Gastrointest Oncol 2014;5:414-20. [PMID: 25436119 DOI: 10.3978/j.issn.2078-6891.2014.078] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
221 Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, de Jong MC, de Vries JJJ, Zonderhuis BM, Eker HH, Kazemier G, Verheul H, van der Meijs BB, van Dam L, Sorgedrager N, Coupé VMH, van den Tol PMP, Meijerink MR; COLLISION Trial Group. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial. BMC Cancer 2018;18:821. [PMID: 30111304 DOI: 10.1186/s12885-018-4716-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
222 Thomas RL, Lordan JT, Devalia K, Quiney N, Fawcett W, Worthington TR, Karanjia ND. Liver resection for colorectal cancer metastases involving the caudate lobe. Br J Surg 2011;98:1476-82. [PMID: 21755500 DOI: 10.1002/bjs.7592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
223 Akgül &, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol 2014; 20(20): 6113-6122 [PMID: 24876733 DOI: 10.3748/wjg.v20.i20.6113] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
224 Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto Y, Nasu K, Fukunaga K, Morishita Y, Minami M. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study. Radiology. 2009;251:557-565. [PMID: 19251941 DOI: 10.1148/radiol.2512081161] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
225 Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E;  Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225-1239. [PMID: 22962059 DOI: 10.1634/theoncologist.2012-0121] [Cited by in Crossref: 284] [Cited by in F6Publishing: 255] [Article Influence: 28.4] [Reference Citation Analysis]
226 Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN. Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg. 2016;223:99-108. [PMID: 26968325 DOI: 10.1016/j.jamcollsurg.2015.12.057] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
227 Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, Azoulay D, Bismuth H, Castaing D, Adam R. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248:994-1005. [PMID: 19092344 DOI: 10.1097/sla.0b013e3181907fd9] [Cited by in Crossref: 248] [Cited by in F6Publishing: 79] [Article Influence: 19.1] [Reference Citation Analysis]
228 Mckenzie SP, Vargas HD, Evers BM, Davenport DL. Selection criteria for combined resection of synchronous colorectal cancer hepatic metastases: a cautionary note. Int J Colorectal Dis 2014;29:729-35. [DOI: 10.1007/s00384-013-1828-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
229 Nijkamp MW, Borren A, Govaert KM, Hoogwater FJ, Molenaar IQ, van Diest PJ, Kranenburg O, Borel Rinkes IH. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surg Oncol 2010;101:551-6. [PMID: 20461760 DOI: 10.1002/jso.21570] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
230 Coffman AR, Sufficool DC, Kang JI, Hsueh CT, Swenson S, McGee PQ, Nagaraj G, Patyal B, Reeves ME, Slater JD, Yang GY. Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions. J Gastrointest Oncol 2021;12:1753-60. [PMID: 34532125 DOI: 10.21037/jgo-20-424] [Reference Citation Analysis]
231 Simons JP, Hill JS, Ng SC, Shah SA, Zhou Z, Whalen GF, Tseng JF. Perioperative mortality for management of hepatic neoplasm: a simple risk score. Ann Surg. 2009;250:929-934. [PMID: 19855257 DOI: 10.1097/sla.0b013e3181bc9c2f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
232 Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol. 2008;15:144-157. [PMID: 17906898 DOI: 10.1245/s10434-007-9478-5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
233 Franceschini D, Cozzi L, De Rose F, Navarria P, Franzese C, Comito T, Iftode C, Tozzi A, Di Brina L, Ascolese AM, Clerici E, D'Agostino G, Fogliata A, Scorsetti M. Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours. J Cancer Res Clin Oncol. 2017;143:1293-1299. [PMID: 28258344 DOI: 10.1007/s00432-017-2373-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
234 Aksoy E, Aliyev S, Taskin HE, Birsen O, Mitchell J, Siperstein A, Berber E. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases. Surgery 2013;154:748-52; discussion 752-4. [PMID: 24074411 DOI: 10.1016/j.surg.2013.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
235 Cacciola A, Parisi S, Tamburella C, Lillo S, Ferini G, Molino L, Iatì G, Pontoriero A, Bottari A, Mazziotti S, Cicero G, Minutoli F, Blandino A, Pergolizzi S. Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? Rep Pract Oncol Radiother 2020;25:299-306. [PMID: 32194349 DOI: 10.1016/j.rpor.2020.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
236 Lemke J, Cammerer G, Ganser J, Scheele J, Xu P, Sander S, Henne-Bruns D, Kornmann M. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment. Clin Colorectal Cancer. 2016;15:e183-e192. [PMID: 27269232 DOI: 10.1016/j.clcc.2016.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
237 Lee WS, Kim MJ, Yun SH, Chun HK, Lee WY, Kim SJ, Choi SH, Heo JS, Joh JW, Kim YI. Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg 2008;393:13-9. [PMID: 17909846 DOI: 10.1007/s00423-007-0231-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
238 Suzuki H, Fujii T, Asao T, Tsutsumi S, Wada S, Araki K, Kubo N, Watanabe A, Tsukagoshi M, Kuwano H. Extracapsular Lymph Node Involvement is Associated With Colorectal Liver Metastases and Impact Outcome After Hepatectomy for Colorectal Metastases. World J Surg 2014;38:2079-88. [DOI: 10.1007/s00268-014-2488-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
239 Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol. 2014;5:374-387. [PMID: 25276410 DOI: 10.3978/j.issn.2078-6891.2014.064] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
240 Calandri M, Yamashita S, Gazzera C, Fonio P, Veltri A, Bustreo S, Sheth RA, Yevich SM, Vauthey J, Odisio BC. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol 2018;28:2727-34. [DOI: 10.1007/s00330-017-5273-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
241 Stintzing S, Hoffmann R, Heinemann V, Kufeld M, Muacevic A. Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients. European Journal of Cancer 2010;46:1026-32. [DOI: 10.1016/j.ejca.2010.01.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
242 Sindram D, Lau KN, Martinie JB, Iannitti DA. Hepatic tumor ablation. Surg Clin North Am. 2010;90:863-876. [PMID: 20637953 DOI: 10.1016/j.suc.2010.04.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
243 Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008;15:227-232. [PMID: 17882491 DOI: 10.1245/s10434-007-9625-z] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
244 Mahnken AH, Pereira PL, de Baère T. Interventional oncologic approaches to liver metastases. Radiology 2013;266:407-30. [PMID: 23362094 DOI: 10.1148/radiol.12112544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
245 Stippel DL, Bangard C, Prenzel K, Yavuzyasar S, Fischer JH, Hölscher AH. Which parameters are needed for targeting a multitined radiofrequency device--an approach to a simple algorithm. Langenbecks Arch Surg 2009;394:671-9. [PMID: 18288484 DOI: 10.1007/s00423-008-0306-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
246 Snoeren N, Huiskens J, Rijken AM, van Hillegersberg R, van Erkel AR, Slooter GD, Klaase JM, van den Tol PM, Ten Kate FJ, Jansen MC, van Gulik TM. Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol 2011;18:3702-10. [PMID: 21590455 DOI: 10.1245/s10434-011-1762-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
247 Wakabayashi T, Hibi T, Yoneda G, Iwao Y, Sawada Y, Hoshino H, Uemura S, Ban D, Kudo A, Takemura Y, Mishima K, Shinoda M, Itano O, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Egawa H, Yamamoto M. Predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: a Japanese multicenter analysis. J Hepatobiliary Pancreat Sci 2019;26:441-8. [PMID: 31271511 DOI: 10.1002/jhbp.654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
248 Meyer JJ, Timmerman RD, Crane CH. Stereotactic Ablative Radiation Therapy: Role in Treatment of Liver Metastases. Curr Colorectal Cancer Rep 2012;8:123-9. [DOI: 10.1007/s11888-012-0119-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
249 Swenson CE, Haemmerich D, Maul DH, Knox B, Ehrhart N, Reed RA. Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model. PLoS One 2015;10:e0139752. [PMID: 26431204 DOI: 10.1371/journal.pone.0139752] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
250 Gunvén P, Blomgren H, Lax I, Levitt SH. Curative stereotactic body radiotherapy for liver malignancy. Med Oncol 2009;26:327-34. [DOI: 10.1007/s12032-008-9125-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
251 Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Dirican B, Beyzadeoglu M. A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases. Int J Surg Oncol 2019;2019:5239042. [PMID: 31139467 DOI: 10.1155/2019/5239042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
252 van Amerongen MJ, Jenniskens SFM, van den Boezem PB, Fütterer JJ, de Wilt JHW. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. HPB (Oxford) 2017;19:749-56. [PMID: 28687147 DOI: 10.1016/j.hpb.2017.05.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
253 Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 2007;11:66-72. [PMID: 17390189 DOI: 10.1007/s11605-006-0045-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
254 Mitin T, Enestvedt CK, Thomas CR Jr. Management of oligometastatic rectal cancer: is liver first? J Gastrointest Oncol 2015;6:201-7. [PMID: 25830039 DOI: 10.3978/j.issn.2078-6891.2014.086] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
255 White RR, Avital I, Sofocleous CT, Brown KT, Brody LA, Covey A, Getrajdman GI, Jarnagin WR, Dematteo RP, Fong Y. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg. 2007;11:256-263. [PMID: 17458595 DOI: 10.1007/s11605-007-0100-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
256 Tamandl D, Ba-Ssalamah A, Böhm G, Emmanuel K, Forstner R, Függer R, Henninger B, Koch O, Kölblinger C, Mischinger HJ, Schima W, Schöllnast H, Stättner S, Kaczirek K. Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions. Wien Klin Wochenschr 2018;130:665-72. [PMID: 30167887 DOI: 10.1007/s00508-018-1387-z] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
257 Benešová L, Hálková T, Ptáčková R, Semyakina A, Menclová K, Pudil J, Ryska M, Levý M, Šimša J, Pazdírek F, Hoch J, Blaha M, Minárik M. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA. World J Gastroenterol 2019; 25(48): 6939-6948 [PMID: 31908397 DOI: 10.3748/wjg.v25.i48.6939] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
258 Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Poston G. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis. 2011;13:e252-e265. [PMID: 21689362 DOI: 10.1111/j.1463-1318.2011.02695.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 11.0] [Reference Citation Analysis]
259 Folkert MR, Timmerman RD. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT). Adv Drug Deliv Rev 2017;109:3-14. [PMID: 27932046 DOI: 10.1016/j.addr.2016.11.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
260 Hallet J, Cunha AS, Adam R, Goéré D, Azoulay D, Mabrut JY, Muscari F, Laurent C, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group. Association Française de Chirurgie (AFC). Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database. Ann Surg Oncol 2016;23:894-903. [PMID: 27573524 DOI: 10.1245/s10434-016-5506-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
261 Tzeng CW, Aloia TA. Colorectal liver metastases. J Gastrointest Surg. 2013;17:195-201; quiz 201-202. [PMID: 23054896 DOI: 10.1007/s11605-012-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Stoltz A, Gagnière J, Dupré A, Rivoire M. Radiofrequency ablation for colorectal liver metastases. J Visc Surg 2014;151 Suppl 1:S33-44. [PMID: 24582728 DOI: 10.1016/j.jviscsurg.2013.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
263 Wada Y, Morine Y, Imura S, Ikemoto T, Saito Y, Takasu C, Yamada S, Shimada M. HIF-1α expression in liver metastasis but not primary colorectal cancer is associated with prognosis of patients with colorectal liver metastasis. World J Surg Oncol 2020;18:241. [PMID: 32895059 DOI: 10.1186/s12957-020-02012-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, Villaflor VM, Stadler WM, Hoffman PC, Cohen EE, Connell PP, Haraf DJ, Vokes EE, Hellman S, Weichselbaum RR. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012;118:2962-2970. [PMID: 22020702 DOI: 10.1002/cncr.26611] [Cited by in Crossref: 211] [Cited by in F6Publishing: 207] [Article Influence: 19.2] [Reference Citation Analysis]